LATE-BREAKING ABSTRACT: Aspergillus fumigatus specific IgE, but not total IgE or A. fumigatus specific IgG is associated with evidence of lung damage in asthma

Kerry Woolnough (Lichfield, United Kingdom), Kerry Woolnough, Catherine Pashley, Andrew Wardlaw

Source: International Congress 2015 – Emerging strategies for airway disease treatments
Session: Emerging strategies for airway disease treatments
Session type: Thematic Poster Session
Number: 4357
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Kerry Woolnough (Lichfield, United Kingdom), Kerry Woolnough, Catherine Pashley, Andrew Wardlaw. LATE-BREAKING ABSTRACT: Aspergillus fumigatus specific IgE, but not total IgE or A. fumigatus specific IgG is associated with evidence of lung damage in asthma. Eur Respir J 2015; 46: Suppl. 59, 4357

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LATE-BREAKING ABSTRACT: IgE sensitisation to A. fumigatus is associated with fixed airflow obstruction independent of atopic status
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015


Aspergillus fumigatus sensitization in COPD and smokers
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015

Evidence for local IgE production to Aspergillus fumigatus in children with cystic fibrosis
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009


The contribution of Aspergillus fumigatus to COPD exacerbations: a “sensitive” topic
Source: Eur Respir J, 56 (2) 2002223; 10.1183/13993003.02223-2020
Year: 2020



Allergic bronchopulmonary aspergillosis (ABPA) prevalence in adult cystic fibrosis (CF) patients. Usefulness of recombinant Aspergillus fumigatus IgE (rAsp f) in diagnosis and monitoring treatment
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis
Year: 2012

Diagnostic value of combined sIgG and sIgE of Aspergillus fumigatus in allergic broncho pulmonary aspergillosis and severe asthma with fungal sensitation
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019

Sensitisation to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD
Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes
Year: 2017



IgE expression in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA)
Source: Annual Congress 2013 –Asthma
Year: 2013


Models to mimic allergic asthma using house dust mite or Aspergillus fumigatus in mice: advantages and disadvantages
Source: Annual Congress 2005 - PG11 - Experimental models for COPD and asthma
Year: 2005


Serologic immunoglobulin E responses against Aspergillus and Candida in patients with chronic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 280s
Year: 2005

Clinical application and radiological relavance for Aspergillus fumigatus- and flavus-specific IgG in chronic Pulmonary Aspergillus infection>
Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Year: 2020


Adult asthma patients reporting exacerbations triggered by upper airway infection have increased total IgE and sensitization to HDM
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014


Impact of Aspergillus fumigatus infection on lung function in children with cystic fibrosis
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021


Peripheral blood eosinophilia and sensitization to Aspergillus fumigatus in adult patients (pts) with non-cystic fibrosis bronchiectasis (B)
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019

Increased total, secretory and NTHi-specific IgA in the COPD airway
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015

Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrations
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015


Performance of Siemens immulite immunoassay for detection of Aspergillus fumigatus and Aspergillus flavus specific IgG for chronic pulmonary aspergillosis diagnosis in Pakistan
Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Year: 2020


IgE sensitization to Aspergillus fumigatus among children in allergological centre of Saratov
Source: International Congress 2017 – Many faces of asthma and allergies
Year: 2017

Aspergillus fumigatus-specific immunoglobulin levels in BALF of CF patients
Source: ERJ Open Res, 3 (4) 00067-2017; 10.1183/23120541.00067-2017
Year: 2017



Serum level of specific IgG antibody for aspergillus and its association with severity of asthma in asthmatic children
Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases
Year: 2012